ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q28262100

Q28262100

about

Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma Predictive value of BRCA1 expression on the efficacy of chemotherapy based on anti-microtubule agents: a pooled analysis across different malignancies and agents Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.The use of pharmacogenomics for selection of therapy in non-small-cell lung cancer Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes.Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancer Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers.Regulatory landscape and clinical implication of MBD3 in human malignant glioma.Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer.Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.Effects of p38MAPK-mediated excision repair cross-complementation 1 expression on prognosis of patients with non-small cell lung cancer.A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.[Correlation between expression of TUBB3/STMN1 and EGFR signaling pathway in non-small cell lung cancer].Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.Genomic Studies Reveal New Aspects of the Biology of DNA Damaging Agents.ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.[BRCA1: a new predictive genomic marker for chemotherapy and radiotherapy of non-small cell lung cancer].

P2860

Q21198839-F8183DC2-1582-47EB-9806-9629BD6839B8 Q21558626-6CC2A162-5DF9-4A91-A363-FA57B14E65F4 Q26748931-17DE43C2-CE41-4D05-9848-6338D07B9C48 Q27009492-A0CCCA20-7AAA-4DEB-A2E1-CC505E3362A5 Q34517369-B022E964-67A7-45F5-8310-E0E83E43DDB3 Q34657144-A2164123-FB50-4D36-B4E1-E7303C20DDD3 Q34994818-4A061A5F-E64F-4961-861D-DB772489ED1E Q35125240-B12F6038-A0D7-4904-8A36-166D1C9C033C Q36057191-111F40F3-1741-4308-ABD5-319FEFE57B38 Q36088616-49F2FE81-458E-40AE-8E23-31892DB75011 Q36893674-1F6FF054-BEC1-4419-8A12-06056F2ACD28 Q36900849-DAF88E58-5149-4440-811D-80A85045186A Q37553893-89B90DCB-0E90-44C1-A19D-B25F3A8E9B1A Q37684657-EBDE9CD3-FD9D-4A9B-BEF1-5B0B43DA4C49 Q37728648-A3E9D4B7-5873-461B-95B7-E450B160D751 Q38203468-20A9CC78-3754-464A-B1E0-D7E5DF883E3F Q41260004-8A28F6DC-836D-4FD0-AA11-CECF403B2E21 Q41615810-93E27CF2-A213-4564-B4B4-BD803EA407A9 Q41686298-83CD18C4-0E39-4E73-ADB8-2F3044DDA0D4 Q44876602-B42B1D6E-4E81-4427-B0D0-AA8B328B9455 Q46708052-F91096AA-094C-4D72-807F-9B4910BB0A44 Q47140849-604258B7-D811-42D9-A8C3-07EA207DAE35 Q47875319-A0B00D4F-9F40-4B70-8A7D-E5AE6A3305B2 Q53627469-629D33DC-6497-4A50-AF19-C419869A2526 Q55464315-6BA04184-A7FB-43E3-A81D-6F1B200FCEC1

P2860

ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q28262100

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu